Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 31st Annual Congress of the European Society of Cardiology
Hypertension Management: Prevention and Treatment of Heart Failure
Barcelona, Spain / August 29-September 2, 2009
Barcelona - Evidence suggests that not all classes of antihypertensive agents are equivalent in their ability to reduce the development of heart failure. A large number of studies have demonstrated that angiotensin receptor blockers (ARBs),...
PRIORITY PRESS - 31st Annual Congress of the European Society of Cardiology
Advances in Drug-eluting Stents
Barcelona, Spain / August 29-September 2, 2009
Barcelona - The current generation of stents are the product of a series of innovations that have resulted in very low rates of early complications, but even subtle differences in current devices have the potential to translate into...
PRIORITY PRESS - 31st Annual Congress of the European Society of Cardiology
Evidence for Triple Antiplatelet Strategies in ACS
Barcelona, Spain / August 29-September 2, 2009
Barcelona - The era of triple antiplatelet therapy in acute coronary syndromes (ACS) was initiated by a series of key studies that changed guidelines. The addition of a glycoprotein IIb/IIIa antagonist to ASA/clopidogrel, prasugrel or...
PRIORITY PRESS - 31st Annual Congress of the European Society of Cardiology
Patient Characteristics and Antiplatelet Choice in ACS/STEMI
Barcelona, Spain / August 29-September 2, 2009
Barcelona - In patients with acute coronary syndromes (ACS) and ST-segment elevated myocardial infarction (STEMI), clinicians are being urged to individualize antiplatelet therapy more actively. As thrombotic risk increases, the net...
PRIORITY PRESS - 31st Annual Congress of the European Society of Cardiology
STRIDE-3: Selective Endothelin in Pulmonary Arterial Hypertension Management
Barcelona, Spain / August 29-September 2, 2009
Barcelona - Pulmonary arterial hypertension (PAH) is characterized by increases in pulmonary artery pressure and vascular resistance leading to right ventricular failure and death. Endothelin (ET)-1 is a potent endogenous vasoconstrictor...
JOURNAL CLUB - VTE Prophylaxis
New Oral Anticoagulants: Enhanced VTE Prophylaxis After Total Joint Arthroplasty
June 2009
Editorial Overview: Jeffrey Weitz, MD, FACP, FRCPC, FCCP, FAHA Director, Henderson Research Centre, Professor, Departments of Medicine and Biochemistry and Biomedical Sciences, Canada Research Chair in Thrombosis, HSFO/J.F. Mustard Chair in...
PRIORITY PRESS - 19th European Meeting on Hypertension
Importance of Renin-Angiotensin Blockade: The Anchor in Blood Pressure Control
Milan, Italy / June 12-16, 2009
Milan - According to investigators here this week,for patients with grade 2 or higher hypertension, combination therapy is now recommended as the initial treatment step in many major guidelines. Presentations during the scientific sessions...
PHYSICIAN PERSPECTIVE Viewpoint based on the following article: J Am Soc Nephrol 2009;20(4):893-900.
Advances in Renoprotection and Cardiovascular Outcomes
April 2009
INTRODUCTION Uncontrolled high blood pressure (BP) contributes to deterioration of renal function, and optimizing BP is the primary means to reduce renal failure. However, large-scale clinical trials have demonstrated that...
PRIORITY PRESS - 29th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation
Immunosuppression in Heart Transplant Patients at High Risk for Poor Outcomes
Paris, France / April 22-25, 2009
Paris - The field of heart transplantation was revolutionized in the 1970s by the introduction of safer and more effective immunosuppressive regimens that significantly increased the chances that cardiac graft recipients could survive for...